SNY [NASD]
Sanofi
Index- P/E15.15 EPS (ttm)2.72 Insider Own16.40% Shs Outstand2.50B Perf Week-5.14%
Market Cap102.68B Forward P/E9.24 EPS next Y4.46 Insider Trans0.00% Shs Float2.26B Perf Month-17.44%
Income6.84B PEG1.23 EPS next Q1.36 Inst Own10.40% Short Float0.13% Perf Quarter-20.96%
Sales43.37B P/S2.37 EPS this Y-49.30% Inst Trans1.96% Short Ratio0.98 Perf Half Y-22.64%
Book/sh29.28 P/B1.41 EPS next Y5.04% ROA- Target Price67.89 Perf Year-21.33%
Cash/sh2.86 P/C14.43 EPS next 5Y12.30% ROE- 52W Range40.92 - 57.79 Perf YTD-17.34%
Dividend1.75 P/FCF- EPS past 5Y7.80% ROI7.20% 52W High-28.73% Beta0.46
Dividend %4.24% Quick Ratio0.90 Sales past 5Y2.50% Gross Margin69.40% 52W Low0.66% ATR1.50
Employees95442 Current Ratio1.30 Sales Q/Q16.00% Oper. Margin- RSI (14)25.03 Volatility2.46% 2.23%
OptionableYes Debt/Eq0.30 EPS Q/Q15.20% Profit Margin- Rel Volume0.00 Prev Close41.19
ShortableYes LT Debt/Eq0.26 EarningsJul 28 BMO Payout- Avg Volume2.89M Price41.19
Recom1.20 SMA20-13.30% SMA50-16.51% SMA200-19.19% Volume0 Change0.00%
Aug-12-22Upgrade Deutsche Bank Sell → Hold
Aug-09-22Downgrade UBS Buy → Neutral
May-23-22Initiated SVB Leerink Outperform
Sep-27-21Upgrade SVB Leerink Mkt Perform → Outperform
Jan-15-21Initiated Deutsche Bank Sell
Sep-29-20Initiated Berenberg Hold
Mar-17-20Upgrade Barclays Underweight → Equal Weight
Mar-11-20Upgrade Goldman Neutral → Buy
Feb-11-20Initiated SVB Leerink Mkt Perform
Jan-06-20Upgrade JP Morgan Neutral → Overweight
Sep-23-19Upgrade Guggenheim Neutral → Buy
Sep-20-19Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-03-19Initiated Bernstein Outperform
Aug-14-19Upgrade UBS Neutral → Buy
Dec-11-18Upgrade Jefferies Hold → Buy
Nov-01-18Upgrade Barclays Underweight → Equal Weight
Oct-09-18Initiated Guggenheim Neutral
Sep-10-18Upgrade BofA/Merrill Neutral → Buy
Aug-10-18Upgrade Citigroup Neutral → Buy
Mar-23-18Upgrade Liberum Hold → Buy
Aug-17-22 04:33PM  
02:28PM  
12:39PM  
12:32PM  
09:17AM  
07:09AM  
06:49AM  
06:25AM  
04:50AM  
03:59AM  
01:47AM  
01:41AM  
01:30AM  
Aug-16-22 04:29PM  
11:45AM  
Aug-14-22 11:09AM  
Aug-12-22 04:09PM  
03:07PM  
11:00AM  
10:01AM  
09:50AM  
06:50AM  
04:24AM  
03:41AM  
03:28AM  
12:25AM  
Aug-11-22 05:01PM  
04:16PM  
03:01PM  
02:51PM  
01:10PM  
11:12AM  
07:18AM  
Aug-08-22 03:03PM  
Aug-05-22 02:08PM  
11:13AM  
Aug-04-22 02:19PM  
11:30AM  
Aug-03-22 02:53PM  
11:57AM  
10:53AM  
Aug-01-22 08:10AM  
07:38AM  
Jul-29-22 11:30AM  
10:20AM  
Jul-28-22 08:02PM  
04:09PM  
12:11PM  
08:29AM  
08:24AM  
02:20AM  
01:33AM  
01:30AM  
Jul-27-22 02:23PM  
Jul-26-22 07:00AM  
Jul-25-22 12:03PM  
09:45AM  
Jul-20-22 12:52PM  
Jul-15-22 07:48AM  
Jul-14-22 10:56AM  
06:18AM  
01:00AM  
Jul-13-22 12:38PM  
Jul-12-22 04:00AM  
Jul-11-22 02:23PM  
07:02AM  
06:25AM  
Jul-10-22 09:45AM  
09:45AM  
Jul-09-22 11:00AM  
Jul-06-22 02:25PM  
Jul-04-22 06:00AM  
Jul-01-22 05:04PM  
11:45AM  
06:57AM  
Jun-30-22 04:11PM  
09:25AM  
08:46AM  
07:38AM  
Jun-29-22 12:08PM  
08:56AM  
07:44AM  
Jun-28-22 10:14AM  
01:30AM  
01:30AM  
Jun-27-22 04:57PM  
11:01AM  
03:00AM  
Jun-25-22 10:23AM  
08:09AM  
Jun-24-22 04:08PM  
09:50AM  
08:54AM  
08:27AM  
07:29AM  
03:39AM  
03:15AM  
01:32AM  
01:29AM  
Jun-13-22 04:44PM  
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.